Vaginal recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: A case report

Case Reports in Oncology

Volumn 4, Issue 1, 2011, Pages 242-245

  Yechieli, Raphael ^a   Robbins, Jared R ^a   Schultz, Daniel ^b   Munkarah, Adnan ^c   Elshaikh, Mohamed A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b Department of Anatomic Pathology ^*  (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Brachytherapy; Late recurrence; Salvage treatment; Uterine carcinoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BIOPSY TECHNIQUE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CURETTAGE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; METASTASIS; MYOMETRIUM; PAPANICOLAOU TEST; PELVIC EXAMINATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SALVAGE BRACHYTHERAPY; SALVAGE THERAPY; THICKNESS; VAGINAL CUFF BIOPSY;

EID: 79957617871     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000328076     Document Type: Article

References (13)

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Creutzberg CL, van Putten WLJ, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M; PORTEC Study Group: Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 2003;89:201-209. (Pubitemid 36457866)
3. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG; Gynecologic Oncology Group: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-751. (Pubitemid 38251372)
4. Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH: Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 2007;62:28-34. (Pubitemid 44824747)
5. Kong A, Johnson N, Cornes P, Simera I, Collingwood M, Williams C, Kitchener H: Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2007;CD003916.
6. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T; Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group: Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 2006;101:520-529.
7. Lederman GS, Niloff JM, Redline R, Rosen EM: Late recurrence in endometrial carcinoma. Cancer 1987;59:825-828. (Pubitemid 17018765)
8. Lorenz U, Gassel AM, Thiede A, Gassel HJ: Endometrial carcinoma recurrence in an abdominal scar 14 years after total hysterectomy. Gynecol Oncol 2004;95:393-395. (Pubitemid 39445878)
9. Tsurumaki Y, Kume H, Homma Y: Late recurrence of uterine endometrioid carcinoma in the upper urinary tract. Arch Gynecol Obstet 2009;280:631-632.
10. Petignat P, Jolicoeur M, Alobaid A, Drouin P, Gauthier P, Provencher D, Donath D, Van Nguyen T: Salvage treatment with high-dose-rate brachytherapy for isolated vaginal recurrence. Gynecol Oncol 2006;101:445-449. (Pubitemid 43729967)
11. Kobayashi S, Sasaki M, Goto T: Endometrioid adenocarcinoma arising from endometriosis of the rectosigmoid. Dig Endosc 2010;22:59-63.
12. Ueda Y, Matsumura Y, Egawa-Takata T, Miyake T, Miyatake T, Yoshino K, Fujita M, Matsuzaki S, Yokoyama T, Miyoshi Y, Yamasaki M, Enomoto T, Kimura T: Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma. Anticancer Res 2010;30:4347-4352.
13. Sartori E, Laface B, Gadducci A, Maggino T, Zola P, Landoni F, Zanagnolo V: Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. Int J Gynecol Cancer 2003;13:458-465. (Pubitemid 38220663)